SABCS: Risk-Based Screening Noninferior for Identifying Stage ≥IIB Breast Cancer

WEDNESDAY, Dec. 17, 2025 -- Risk-based screening, including genetic testing, is noninferior to annual screening for detecting stage ≥IIB cancers and does not reduce biopsy rates despite fewer mammograms, according to a study published online Dec...